Sign Up to like & get
recommendations!
0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-63825-8
Abstract: Lowering low-density lipoprotein (LDL-C) and triglyceride (TG) levels form the cornerstone approach of cardiovascular risk reduction, and a higher high-density lipoprotein (HDL-C) is thought to be protective. However, in acute myocardial infarction (AMI) patients, higher…
read more here.
Keywords:
myocardial infarction;
nstemi patients;
elevation myocardial;
infarction ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.1568
Abstract: Several studies suggest that an alteration of monocyte metabolism might be implicated in inflammatory diseases. Enhanced glycolysis might be a hallmark of pro-inflammatory monocyte subsets. Improved glycolysis enables the immune cells to generate sufficient ATP…
read more here.
Keywords:
pkm;
glycolysis;
monocytes patients;
metabolism ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Thrombosis and haemostasis"
DOI: 10.1160/th16-09-0728
Abstract: It was the study objective to evaluate whether chewing a 180 mg loading dose of ticagrelor versus an equal dose of traditional oral administration, enhances inhibition of platelet aggregation 1 hour (h) after administering a…
read more here.
Keywords:
ticagrelor;
nstemi patients;
inhibition;
group ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-019-1217-x
Abstract: BackgroundAcute Coronary Syndrome (ACS) is one of the leading causes of death worldwide and studies have shown higher mortality rates and premature death in South Asian countries. The occurrence and effect of risk factors differ…
read more here.
Keywords:
stemi patients;
nstemi patients;
risk factors;
epidemiology ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s353199
Abstract: Objective Cardiac microvascular obstruction (CMVO) remains a severe complication in non-ST elevation myocardial infarction (NSTEMI) patients with reperfusion therapy. We aimed at developing and validating the nomogram to predict the possibility of CMVO after primary…
read more here.
Keywords:
primary pci;
microvascular obstruction;
laboratory based;
nstemi patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10122024
Abstract: The COVID-19 pandemic has impacted healthcare delivery to patients with non-ST-segment elevation myocardial infraction (NSTEMI). The aim of our retrospective study is to determine the effect of COVID-19 on inpatient NSTEMI outcomes and to investigate…
read more here.
Keywords:
nstemi outcomes;
nstemi patients;
covid;
mortality ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Acta Cardiologica Sinica"
DOI: 10.6515/acs.202011_36(6).20200326a
Abstract: Background Risk score is widely used in non-ST segment elevation myocardial infarction (NSTEMI) patients to predict the in-hospital outcome for immediate coronary angiography decision and care of unit selection. Objectives This study compared the performances…
read more here.
Keywords:
score;
risk;
long term;
nstemi patients ... See more keywords